These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Implementation of a structured guideline-based program for the secondary prevention of ischemic stroke in China. Peng B; Ni J; Anderson CS; Zhu Y; Wang Y; Pu C; Wu J; Wang J; Zhou L; Yao M; He J; Shan G; Gao S; Xu W; Cui L; Stroke; 2014 Feb; 45(2):515-9. PubMed ID: 24385269 [TBL] [Abstract][Full Text] [Related]
14. Drug treatments in the secondary prevention of ischaemic stroke. Schulz UG Maturitas; 2013 Nov; 76(3):267-71. PubMed ID: 23769546 [TBL] [Abstract][Full Text] [Related]
15. Preventing stroke: a review of current guidelines. Akopov S; Cohen SN J Am Med Dir Assoc; 2003; 4(5 Suppl):S127-32. PubMed ID: 14501806 [No Abstract] [Full Text] [Related]
16. A benefit-risk assessment of agents used in the secondary prevention of stroke. MacWalter RS; Shirley CP Drug Saf; 2002; 25(13):943-63. PubMed ID: 12381215 [TBL] [Abstract][Full Text] [Related]
17. Antithrombotic treatment in the prevention of ischemic stroke. Emre U; Rantanen K; Tatlisumak T Curr Drug Targets; 2007 Jul; 8(7):817-23. PubMed ID: 17630934 [TBL] [Abstract][Full Text] [Related]
18. Standard medical management in secondary prevention of ischemic stroke in China (SMART). Peng B; Zhu Y; Cui L; Ni J; Xu W; Zhou L; Yao M; Chen L; Wang J; Wang Y; Pu C; Int J Stroke; 2011 Oct; 6(5):461-5. PubMed ID: 21951412 [TBL] [Abstract][Full Text] [Related]
19. [Hypertension: most important risk factor of a stroke]. Diehm C MMW Fortschr Med; 2012 Oct; 154(18):73-4. PubMed ID: 23156880 [No Abstract] [Full Text] [Related]
20. Prescription of secondary preventive drugs after ischemic stroke: results from the Malaysian National Stroke Registry. Hwong WY; Abdul Aziz Z; Sidek NN; Bots ML; Selvarajah S; Kappelle LJ; Sivasampu S; Vaartjes I BMC Neurol; 2017 Nov; 17(1):203. PubMed ID: 29169331 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]